“Purdue Pharma Bankruptcy Settlement Signals Major Shift in Opioid Crisis Accountability”
The recent resolution of Purdue Pharma’s bankruptcy case marks a notable development in the legal landscape surrounding the opioid crisis. A federal judge has approved a settlement plan, allowing Purdue Pharma to exit bankruptcy by providing up to $6 billion to aid communities affected by the opioid epidemic. This decision, available for review on Bloomberg…